- cafead   Jun 21, 2024 at 11:22: AM
via Japan's Takeda Pharmaceutical (4502.T) gave India's Sun Pharmaceutical (SUN.NS) and Cipla (CIPL.NS) the rights to commercialize gastrointestinal drug Vonoprazan in the country.
article source
article source